Component: (Network and Table)
Network
00500 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOW
(http://www.vivus.com/role/StatementConsolidatedStatementsOfCashFlow)
Table(Implied)
Slicers (applies to each fact value in each table cell)
CONSOLIDATED STATEMENTS OF CASH FLOWSPeriod [Axis]
2016-01-01 - 2016-12-31
2015-01-01 - 2015-12-31
2014-01-01 - 2014-12-31
CONSOLIDATED STATEMENTS OF CASH FLOWS
 
 
 
Cash flows from operating activities:
 
 
 
Net loss
23,302,000  
(93,107,000) 
(82,647,000) 
Adjustments to reconcile net loss to net cash used for operating activities:
 
 
 
Depreciation and amortization
1,080,000  
1,387,000  
1,112,000  
Amortization of debt issuance costs and discounts
18,666,000  
17,174,000  
15,923,000  
Amortization of discount or premium on available-for-sale securities
944,000  
2,282,000  
4,016,000  
Share-based compensation expense
2,284,000  
3,590,000  
9,766,000  
Loss on disposal of property and equipment
342,000  
  
Inventory impairment charge
 
29,522,000  
2,170,000  
Changes in assets and liabilities:
 
 
 
Accounts receivable
(481,000) 
2,598,000  
619,000  
Inventories
(2,584,000) 
(8,487,000) 
11,886,000  
Prepaid expenses and other assets
1,516,000  
2,639,000  
7,734,000  
Accounts payable
(2,353,000) 
(3,370,000) 
(329,000) 
Accrued and other liabilities
(1,524,000) 
(889,000) 
(9,061,000) 
Deferred revenue
(3,027,000) 
329,000  
706,000  
Net cash provided by (used for) operating activities
38,165,000  
 
(46,332,000) 
 
(38,105,000) 
 
Cash flows from investing activities:
 
 
 
Property and equipment purchases
(211,000) 
(310,000) 
(262,000) 
Purchases of available-for-sale securities
(135,997,000) 
(213,536,000) 
(240,983,000) 
Proceeds from maturity of available-for-sale securities
60,050,000  
281,250,000  
260,500,000  
Proceeds from sale of Available-for-sale Securities
36,080,000  
  
Non-current assets
  
(3,362,000) 
Net cash (used for) provided by investing activities
(40,078,000) 
 
67,404,000  
 
15,893,000  
 
Cash flows from financing activities:
 
 
 
Repayments of noted payable
(8,738,000) 
(8,998,000) 
 
Net proceeds from exercise of common stock options
  
1,719,000  
Sale of common stock through employee stock purchase plan
39,000  
147,000  
405,000  
Net cash (used for) provided by financing activities
(8,699,000) 
 
(8,851,000) 
 
2,124,000  
 
Net increase (decrease) in cash and cash equivalents
(10,612,000) 
 
12,221,000  
 
(20,088,000) 
 
Cash and cash equivalents:
 
 
 
Beginning of period
95,395,000  
83,174,000  
103,262,000  
End of period
84,783,000  
 
95,395,000  
 
83,174,000  
 
Supplemental cash flow disclosure:
 
 
 
Interest paid
15,368,000  
18,756,000  
20,251,000  
Income taxes paid
59,000  
58,000  
94,000  
Non-cash investing activities:
 
 
 
Unrealized loss on securities
(355,000) 
(233,000) 
(94,000)